Premium
Excitation‐Dependent Theranostic Nanosheet for Cancer Treatment
Author(s) -
Guan Shanyue,
Yang Di,
Weng Yangziwan,
Lu Heng,
Meng Xiangmin,
Qu Xiaozhong,
Zhou Shuyun
Publication year - 2018
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201701123
Subject(s) - ruthenium , singlet oxygen , luminescence , supramolecular chemistry , nanosheet , materials science , photochemistry , irradiation , fluorescence , monolayer , hydroxide , excitation , photodynamic therapy , oxygen , nanotechnology , chemistry , crystallography , optoelectronics , catalysis , inorganic chemistry , organic chemistry , crystal structure , physics , engineering , quantum mechanics , nuclear physics , electrical engineering
In this work, a novel ruthenium complex loaded monolayer layered double hydroxide (LDH) (denoted as Ru(C‐bpy) 2 /mLDH) as supramolecular nanosensor is synthesized, which is greatly exclusive to the hypoxic tumor microenvironment. The Ru(C‐bpy) 2 /mLDH ultrathin sheet displays not only enhanced luminescence lifetime compared to the parent Ru(C‐bpy) 2 alone, but also improved oxygen responsibility under an excitation of 488 or 800 nm. Moreover, the Ru(C‐bpy) 2 /mLDH is possessed of two‐photon fluorescence imaging ability under the 800 nm irradiation. In addition, the Ru(C‐bpy) 2 /mLDH can generate singlet oxygen with a high yield (φ ∆ ) of 0.28 under the 520 nm irradiation, while the φ ∆ of Ru(C‐bpy) 2 is 0.19. Therefore, the Ru(C‐bpy) 2 /mLDH can be applied as a supramolecular theranostic agent with light‐switchable cancer imaging and photodynamic therapy properties.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom